Clinical Trial Update: Lenalidomide Maintenance in Plasma Cell Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of lenalidomide as maintenance therapy for plasma cell myeloma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Plasma Cell Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING